Literature DB >> 19059298

Invivo antioxidant status: a putative target of antidepressant action.

Ayesha Zafir1, Anjum Ara, Naheed Banu.   

Abstract

Oxidative stress is a critical route of damage in various psychological stress-induced disorders, such as depression. Antidepressants are widely prescribed to treat these conditions; however, few animal studies have investigated the effect of these drugs on endogenous antioxidant status in the brain. The present study employed a 21-day chronic regimen of random exposure to restraint stress to induce oxidative stress in brain, and behavioural aberrations, in rodents. The forced swimming (FST) and sucrose preference tests were used to identify depression-like phenotypes, and reversal in these indices indicated the effectiveness of treatment with fluoxetine (FLU; 20 mg/kg/day, p.o.; selective serotonin reuptake inhibitor), imipramine (IMI; 10 mg/kg/day, p.o.; tricyclic antidepressant) and venlafaxine (VEN; 10 mg/kg/day, p.o.; dual serotonin/norepinephrine reuptake inhibitor) following restraint stress. The antioxidant status was investigated in the brain of these animals. The results evidenced a significant recovery in the activities of superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione reductase (GR) and glutathione (GSH) levels by antidepressant treatments following a restraint stress-induced decline of these parameters. The severely accumulated lipid peroxidation product malondialdehyde (MDA) and protein carbonyl contents in stressed animals were significantly normalized by antidepressant treatments. The altered oxidative status is implicated in various aspects of cellular function affecting the brain. Thus, it is possible that augmentation of in vivo antioxidant defenses could serve as a convergence point for multiple classes of antidepressants as an important mechanism underlying the neuroprotective pharmacological effects of these drugs observed clinically in the treatment of various stress disorders. Consequently, pharmacological modulation of stress-induced oxidative damage as a possible stress-management approach should be an important avenue of further research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059298     DOI: 10.1016/j.pnpbp.2008.11.010

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  51 in total

1.  Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat.

Authors:  Mmalebuso L Mokoena; Brian H Harvey; Douglas W Oliver; Christiaan B Brink
Journal:  Metab Brain Dis       Date:  2010-05-09       Impact factor: 3.584

Review 2.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

3.  Studies on the protective effects of betaine against oxidative damage during experimentally induced restraint stress in Wistar albino rats.

Authors:  Balaraman Ganesan; Rangasamy Anandan; Pindath Thandayan Lakshmanan
Journal:  Cell Stress Chaperones       Date:  2011-06-30       Impact factor: 3.667

4.  Effects of repeated restraint stress and WiFi signal exposure on behavior and oxidative stress in rats.

Authors:  Haifa Othman; Mohamed Ammari; Mohsen Sakly; Hafedh Abdelmelek
Journal:  Metab Brain Dis       Date:  2017-04-27       Impact factor: 3.584

5.  Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.

Authors:  Ankur Jindal; Radhakrishnan Mahesh; Shvetank Bhatt
Journal:  Psychopharmacology (Berl)       Date:  2014-08-15       Impact factor: 4.530

6.  The inhibition characteristics of human placental glutathione S-transferase-π by tricyclic antidepressants: amitriptyline and clomipramine.

Authors:  Ozlem Dalmizrak; Gulnihal Kulaksiz-Erkmen; Nazmi Ozer
Journal:  Mol Cell Biochem       Date:  2011-05-13       Impact factor: 3.396

7.  Fish oil and antipsychotic drug risperidone modulate oxidative stress in PC12 cell membranes through regulation of cytosolic calcium ion release and antioxidant system.

Authors:  Sevil Altinkiliç; Mustafa Naziroğlu; Abdülhadi Cihangir Uğuz; Ramazan Ozcankaya
Journal:  J Membr Biol       Date:  2010-06-24       Impact factor: 1.843

8.  Diets rich in saturated fat and fructose induce anxiety and depression-like behaviours in the rat: is there a role for lipid peroxidation?

Authors:  Silvia Gancheva; Bistra Galunska; Maria Zhelyazkova-Savova
Journal:  Int J Exp Pathol       Date:  2017-12-06       Impact factor: 1.925

9.  Oxidative stress and glutathione response in tissue cultures from persons with major depression.

Authors:  Sara A Gibson; Željka Korade; Richard C Shelton
Journal:  J Psychiatr Res       Date:  2012-07-28       Impact factor: 4.791

Review 10.  Antidepressant fluoxetine and its potential against colon tumors.

Authors:  Helga Stopper; Sergio Britto Garcia; Ana Maria Waaga-Gasser; Vinicius Kannen
Journal:  World J Gastrointest Oncol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.